Brauzer 1971.

Methods	Allocation: randomly assigned, no further description. Blindness: double. Design: 2 parallel groups, single centre. Duration: 1 to 3 months. Analysis: intention‐to‐treat not performed in the trial. Country: USA.
Participants	Diagnosis: schizophrenia**. N=25. Age: mean 41.8 years. Sex: M 11, F 14. Setting: outpatients. History: only 20% are paranoid schizophrenics.
Interventions	1. Trifluoperazine: dose initially 5 mg/day followed by minimum 8 mg/day and maximum of 19 mg/day, then maintenance dose 13 mg/day. N=13. 2. Molindone: dose initially 10 mg/day, followed by minimum of 18 mg/day and maximum of 38 mg/day, then maintenance dose 25 mg/day. N=12.
Outcomes	Use of antiparkinson agents. Leaving the study early. Unable to use ‐ Mental state: (BPRS ‐ no SD). Side effects ‐ no data.
Notes	**Mixed diagnosis
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear